Reckitt Benckiser Group PLC (RKT)
Industry Household & Personal Products
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
5,994.00p
Buy
5,998.00p
-28.00p (-0.46%)
Prices updated at 12 Dec 2025, 17:00 GMT
| Prices minimum 15 mins delay
Prices in GBX
Reckitt Benckiser Group PLC is a consumer health and hygiene company. It manufactures and sells branded products in the health, hygiene and home categories such as Calgon, Lysol, Finish, and Mucinex.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 14,607m | 14,169m | |
| 8,760m | 8,595m | |
| 3,347m | 3,444m | |
| 22.91 | 24.31 | |
| 1,643m | 1,426m | |
| 3,180m | 2,958m | |
| Sales, General and administrative | 5,079m | 4,831m |
| Interest expenses | 309m | 393m |
| Provision for income taxes | 753m | 672m |
| Operating expenses | 5,413m | 5,151m |
| Income before taxes | 2,401m | 2,104m |
| Net income available to common shareholders | 1,643m | 1,426m |
| 2.292 | 2.036 | |
| Net interest income | -281m | -321m |
| Advertising and promotion | - | - |
| Net investment income, net | 145m | -13m |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 2.287 | 2.032 |
| Free cash flow per share | 2.8375 | 3.1574 |
| Book value/share | 12.8664 | 11.7503 |
| Debt equity ratio | 0.81179 | 1.080012 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 5,302m | 4,598m |
| Current liabilities | 8,338m | 7,943m |
| Total capital | 15,057m | 13,713m |
| Total debt | 8,537m | 8,658m |
| Total equity | 8,448m | 6,699m |
| Total non current liabilities | - | - |
| Loans | 6,609m | 7,014m |
| Total assets | 27,136m | 25,298m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,158m | 760m |
| Common stock | 714m | 687m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 1,156m | 1,380m |
| Cash dividends paid | -1,339m | -1,381m |
| 2,187m | 2,217m | |
| Investments (gains) losses | -466m | -396m |
| 1,380m | 879m | |
| Net income | - | - |
| 2,636m | 2,682m | |
| -449m | -465m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.